Gefitinib Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Gefitinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have certain types of abnormal epidermal growth factor (EGFR) genes, and did not receive cancer medicines in the past. Your doctor will perform a test before you take this medicine.Gefitinib Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Gefitinib Nitroso CAS NO:NA chemically represented as N-(3-Chloro-4-fluorophenyl)-N-(7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-yl)nitrous amide . Synchemia is the leading manufacturing and exporter of Gefitinib Nitroso . We supply Gefitinib Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141095 |
| CAS No | NA |
| Mol.F. | C11H8N2O2 |
| Mol.Wt. | 200.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141096 |
| CAS No | NA |
| Mol.F. | C21H22N2O8 |
| Mol.Wt. | 430.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141097 |
| CAS No | NA |
| Mol.F. | C5H12N2O4 |
| Mol.Wt. | 164.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141098 |
| CAS No | NA |
| Mol.F. | C4H10N2O5 |
| Mol.Wt. | 166.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141099 |
| CAS No | NA |
| Mol.F. | C31H32N6O5 |
| Mol.Wt. | 568.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141100 |
| CAS No | NA |
| Mol.F. | C24H19N5O5 |
| Mol.Wt. | 457.4 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141101 |
| CAS No | NA |
| Mol.F. | C13H19N5O2 |
| Mol.Wt. | 277.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141102 |
| CAS No | NA |
| Mol.F. | C33H34N6O6 |
| Mol.Wt. | 610.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141103 |
| CAS No | NA |
| Mol.F. | C14H17ClN4O5 |
| Mol.Wt. | 356.8 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141104 |
| CAS No | NA |
| Mol.F. | C14H19ClN4O3 |
| Mol.Wt. | 326.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141105 |
| CAS No | NA |
| Mol.F. | C22H23ClN6O3 |
| Mol.Wt. | 454.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141106 |
| CAS No | NA |
| Mol.F. | C22H22ClN7O4 |
| Mol.Wt. | 483.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141107 |
| CAS No | NA |
| Mol.F. | C14H20N4O3 |
| Mol.Wt. | 292.34 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141108 |
| CAS No | NA |
| Mol.F. | C12H13ClN4O2 |
| Mol.Wt. | 280.7 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141109 |
| CAS No | NA |
| Mol.F. | C22H23ClN6O3 |
| Mol.Wt. | 454.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141112 |
| CAS No | NA |
| Mol.F. | C16H18N4O2 |
| Mol.Wt. | 298.3 |
| INV STATUS | CUSTOM SYNTHESIS |